Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Yunnan Botanee Bio-Technology Group Co Ltd
Interest Income Expense
Yunnan Botanee Bio-Technology Group Co Ltd
Interest Income Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
|
Interest Income Expense
¥101.7m
|
CAGR 3-Years
36%
|
CAGR 5-Years
124%
|
CAGR 10-Years
N/A
|
|
|
Hengan International Group Company Ltd
HKEX:1044
|
Interest Income Expense
¥698.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Proya Cosmetics Co Ltd
SSE:603605
|
Interest Income Expense
¥129.5m
|
CAGR 3-Years
43%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
|
|
By-health Co Ltd
SZSE:300146
|
Interest Income Expense
¥86.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-26%
|
CAGR 10-Years
0%
|
|
|
S
|
Shanghai Chicmax Cosmetic Co Ltd
HKEX:2145
|
Interest Income Expense
¥22m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
G
|
Giant Biogene Holding Co Ltd
HKEX:2367
|
Interest Income Expense
¥59.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
Yunnan Botanee Bio-Technology Group Co Ltd
Glance View
In the lush landscape of China's Yunnan province, Yunnan Botanee Bio-Technology Group Co Ltd has emerged as a formidable player in the skincare and beauty industry. This company, with its roots deeply intertwined with the rich biodiversity of the region, focuses on harnessing the natural bounty of botanicals to develop innovative skincare solutions. Their expertise lies in transforming these local plant resources into high-value products, capitalizing on the growing global demand for natural and organic ingredients. Each product is a testament to the company's commitment to sustainability and scientific innovation, appealing to a modern consumer base increasingly conscious about the origins and effectiveness of their skincare products. The company’s business model effectively capitalizes on both upstream and downstream processes in the beauty value chain. By controlling the entire journey from plant cultivation to product formulation and final marketing, Yunnan Botanee ensures quality and authenticity at every stage. Their flagship brand, Winona, has carved out a niche in the sensitive skin category, leveraging cutting-edge dermatological research and traditional Chinese herbal knowledge. This strategic positioning, along with strong direct-to-consumer sales combined with an omnichannel retail strategy, bolsters its revenue streams and enhances brand loyalty. Through this integrated approach, the company not only rides the wave of clean beauty trends but also sets a benchmark for sustainable growth in the industry.
See Also
What is Yunnan Botanee Bio-Technology Group Co Ltd's Interest Income Expense?
Interest Income Expense
101.7m
CNY
Based on the financial report for Dec 31, 2024, Yunnan Botanee Bio-Technology Group Co Ltd's Interest Income Expense amounts to 101.7m CNY.
What is Yunnan Botanee Bio-Technology Group Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
124%
Over the last year, the Interest Income Expense growth was 45%. The average annual Interest Income Expense growth rates for Yunnan Botanee Bio-Technology Group Co Ltd have been 36% over the past three years , 124% over the past five years .